Microbix Biosystems Inc.
MBXBF
$0.19
-$0.01-6.41%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.03M | -837.20K | -1.08M | -1.19M | 14.40K |
| Total Depreciation and Amortization | 333.30K | 302.30K | 317.10K | 321.50K | 298.30K |
| Total Amortization of Deferred Charges | -- | 25.00K | 25.30K | -- | -- |
| Total Other Non-Cash Items | 228.10K | 230.60K | 201.50K | 213.10K | 192.40K |
| Change in Net Operating Assets | 245.90K | -1.59M | 592.10K | -737.70K | 187.60K |
| Cash from Operations | -221.30K | -1.87M | 61.00K | -1.39M | 692.60K |
| Capital Expenditure | -160.10K | -122.20K | -112.00K | -140.70K | -170.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -160.10K | -122.20K | -112.00K | -140.70K | -170.90K |
| Total Debt Issued | -- | -- | 359.30K | -- | -- |
| Total Debt Repaid | -248.80K | -68.70K | -68.70K | -52.90K | -2.03M |
| Issuance of Common Stock | -- | -- | 0.00 | -- | 2.74M |
| Repurchase of Common Stock | -187.60K | -173.70K | -208.30K | -266.70K | -744.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -313.80K | -173.90K | 59.70K | -230.90K | -26.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | -- | 0.00 |
| Net Change in Cash | -695.20K | -2.16M | 8.60K | -1.76M | 495.30K |